GLYCO-IBD: Glycans as new immunomodulators in inflammatory bowel disease: An opportunity for new therapeutic strategies. (Q2905968): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in en: translated_label) |
(Removed claim: co-financing rate (P837): 66.0 percent, Removing co-finance rate from projects in portugal) |
||||||
| Property / co-financing rate | |||||||
| |||||||
| Property / co-financing rate: 66.0 percent / rank | |||||||
Revision as of 15:06, 13 September 2021
Project Q2905968 in Portugal
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | GLYCO-IBD: Glycans as new immunomodulators in inflammatory bowel disease: An opportunity for new therapeutic strategies. |
Project Q2905968 in Portugal |
Statements
166,566.0 Euro
0 references
1 July 2016
0 references
31 December 2019
0 references
IPATIMUP-INSTITUTO DE PATOLOGIA E IMUNOLOGIA MOLECULAR DA UNIVERSIDADE DO PORTO
0 references
Q2993205 (Deleted Item)
0 references
Identifiers
POCI-01-0145-FEDER-016601
0 references